InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.66
+0.06 (0.48%)
Feb 13, 2026, 4:08 PM HKT
InnoCare Pharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -229.64 | -440.63 | -631.26 | -886.59 | -64.55 | -391.4 |
Depreciation & Amortization | 95.59 | 95.59 | 88.15 | 67.48 | 33.08 | 11.19 |
Other Amortization | 11.54 | 11.54 | 11.23 | 0.93 | 0.63 | 0.27 |
Loss (Gain) From Sale of Assets | - | - | - | - | 0 | - |
Asset Writedown & Restructuring Costs | 0.12 | 0.12 | 0.02 | - | - | - |
Loss (Gain) From Sale of Investments | -6.26 | -6.26 | -5.57 | -6.46 | -6.7 | - |
Loss (Gain) on Equity Investments | - | - | - | 9.71 | 0.6 | - |
Stock-Based Compensation | -10.79 | -10.79 | 65.1 | 129.48 | 126.44 | 215.62 |
Provision & Write-off of Bad Debts | 1.5 | 1.5 | 0.27 | - | - | - |
Other Operating Activities | 39.69 | 1.88 | 49.17 | 195.01 | -40.75 | 48.35 |
Change in Accounts Receivable | -63.34 | -63.34 | -194.53 | -82.65 | -45.15 | -0.12 |
Change in Inventory | 47.65 | 47.65 | -42.46 | -52.12 | -8.04 | -1.88 |
Change in Accounts Payable | -2.8 | -2.8 | -5.61 | 34 | 79.08 | -2.68 |
Change in Unearned Revenue | - | - | - | -8.75 | 17.19 | -51.39 |
Change in Other Net Operating Assets | - | - | - | 34.42 | 75.22 | -0.49 |
Operating Cash Flow | -116.75 | -365.55 | -665.49 | -565.55 | 167.06 | -172.52 |
Capital Expenditures | -45.45 | -78.23 | -254.65 | -227.24 | -169.77 | -251 |
Sale of Property, Plant & Equipment | 0.01 | 0 | 0.01 | - | 0.02 | - |
Cash Acquisitions | - | - | 1.15 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -143.09 | -1.44 | -0.27 |
Investment in Securities | -630.09 | 1,056 | 795.85 | -1,529 | -1,638 | -889.03 |
Other Investing Activities | 106.22 | 133.75 | 118.71 | 173.34 | 79.57 | 33.34 |
Investing Cash Flow | -569.31 | 1,111 | 661.06 | -1,726 | -1,730 | -1,107 |
Long-Term Debt Issued | - | 1,185 | 33.8 | 325 | 50 | - |
Total Debt Issued | 378.79 | 1,185 | 33.8 | 325 | 50 | - |
Short-Term Debt Repaid | - | - | - | - | - | -9.02 |
Long-Term Debt Repaid | - | -990.41 | -28.98 | -21.78 | -14.92 | -4.99 |
Total Debt Repaid | -201.33 | -990.41 | -28.98 | -21.78 | -14.92 | -14.02 |
Net Debt Issued (Repaid) | 177.47 | 194.91 | 4.82 | 303.23 | 35.08 | -14.02 |
Issuance of Common Stock | 18.76 | 18.5 | 9.95 | 2,923 | 2,527 | 2,356 |
Repurchase of Common Stock | -13.35 | -13.35 | -6.3 | - | - | - |
Common Dividends Paid | -32.88 | -362.93 | -1.15 | - | - | - |
Other Financing Activities | -35.69 | -122.73 | -6.01 | -131.95 | -17.74 | -103.87 |
Financing Cash Flow | 114.31 | -285.59 | 1.31 | 3,095 | 2,545 | 2,238 |
Foreign Exchange Rate Adjustments | 4.53 | 16.92 | 25.7 | 139.9 | -45.3 | -251.78 |
Net Cash Flow | -567.23 | 476.9 | 22.58 | 942.5 | 936.6 | 706.73 |
Free Cash Flow | -162.21 | -443.78 | -920.14 | -792.79 | -2.71 | -423.51 |
Free Cash Flow Margin | -11.37% | -43.96% | -124.59% | -126.76% | -0.26% | -31049.41% |
Free Cash Flow Per Share | -0.10 | -0.26 | -0.54 | -0.54 | -0.00 | -0.44 |
Cash Interest Paid | - | - | - | 3.26 | 2.53 | 1.14 |
Cash Income Tax Paid | 127.45 | 89.25 | 58.78 | - | - | - |
Levered Free Cash Flow | -269.17 | -664.21 | -777.19 | -236.95 | 35.82 | -412.99 |
Unlevered Free Cash Flow | -234.82 | -643.09 | -755.19 | -226.29 | 37.47 | -412.28 |
Change in Working Capital | -18.49 | -18.49 | -242.6 | -75.1 | 118.3 | -56.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.